Your browser doesn't support javascript.
loading
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi, Munyaradzi; Huang, Huang; Wang, Chunlin; Xia, Qiong; Rozot, Virginie; Krishnan, Akshaya; Acs, Peter; Cheruku, Abhilasha; Obermoser, Gerlinde; Leslie, Alasdair; Behar, Samuel M; Hanekom, Willem A; Bilek, Nicole; Fisher, Michelle; Kaufmann, Stefan H E; Walzl, Gerhard; Hatherill, Mark; Davis, Mark M; Scriba, Thomas J.
Afiliação
  • Musvosvi M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Huang H; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
  • Wang C; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
  • Xia Q; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
  • Rozot V; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Krishnan A; Human Immune Monitoring Center, Stanford University, Stanford, CA, USA.
  • Acs P; Human Immune Monitoring Center, Stanford University, Stanford, CA, USA.
  • Cheruku A; Human Immune Monitoring Center, Stanford University, Stanford, CA, USA.
  • Obermoser G; Human Immune Monitoring Center, Stanford University, Stanford, CA, USA.
  • Leslie A; Africa Health Research Institute, Durban, South Africa.
  • Behar SM; School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Hanekom WA; Department of Infection and Immunity, University College London, London, UK.
  • Bilek N; Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Fisher M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Kaufmann SHE; Africa Health Research Institute, Durban, South Africa.
  • Walzl G; School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Davis MM; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Scriba TJ; Max Planck Institute for Infection Biology, Berlin, Germany.
Nat Med ; 29(1): 258-269, 2023 01.
Article em En | MEDLINE | ID: mdl-36604540
ABSTRACT
Antigen-specific, MHC-restricted αß T cells are necessary for protective immunity against Mycobacterium tuberculosis, but the ability to broadly study these responses has been limited. In the present study, we used single-cell and bulk T cell receptor (TCR) sequencing and the GLIPH2 algorithm to analyze M. tuberculosis-specific sequences in two longitudinal cohorts, comprising 166 individuals with M. tuberculosis infection who progressed to either tuberculosis (n = 48) or controlled infection (n = 118). We found 24 T cell groups with similar TCR-ß sequences, predicted by GLIPH2 to have common TCR specificities, which were associated with control of infection (n = 17), and others that were associated with progression to disease (n = 7). Using a genome-wide M. tuberculosis antigen screen, we identified peptides targeted by T cell similarity groups enriched either in controllers or in progressors. We propose that antigens recognized by T cell similarity groups associated with control of infection can be considered as high-priority targets for future vaccine development.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul
...